- Single Injection
- Three Injection
- Five Injection
Viscosupplementation Market size was valued at USD 2.2 billion in 2022 and is expected to reach a value of USD 3.4 billion by 2029, growing at a CAGR of 6.6% from 2023 to 2029. The global market provides a detailed overview of the Viscosupplementation Market, which has been segmented by product and end-user. By product, the viscosupplementation market has been segmented into Single Injections, Three Injections, and Five injections. The Single Injection segment is likely to be the largest and fastest-growing segment in terms of product type. Based on the end-user, the viscosupplementation is segmented into Hospitals, Orthopedic Clinics/Ambulatory Surgical Centers (ASCs), and Others. According to precision business insights, the Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) segment is predicted to register the fastest growth rate during the forecast period.
Viscosupplementation Market Key Developments:
In February 2020, Anika Therapeutics, Inc. acquired the Arthrosurface, a privately held manufacturer of preservation solutions and joint surfaces for active patients.
Viscosupplementation Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
6.6%
Largest Market
Asia Pacific
Fastest Growing Market
Asia-Pacific
Viscosupplementation Market Dynamics
The market is likely to be driven by increasing demand for non-surgical treatments for osteoarthritis, the prevalence of lifestyle-induced problems, and developments in creating hyaluronic acid-based therapies.
Asia-Pacific Got Significant Share
Viscosupplementation Market Regional Analysis
Asia Pacific is the fastest growing region in Viscosupplementation Market compared to other regions
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The viscosupplementation market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
- The viscosupplementation market report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The viscosupplementation market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The viscosupplementation market report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The viscosupplementation market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Viscosupplementation Market Segmentation
By Product
By End User
- Hospitals
- Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The Viscosupplementation Market is projected to expand at a CAGR of 6.6% during the forecast period.
The major players in the global viscosupplementation market are Sanofi, Anika Therapeutics, Inc., Seikagaku Corp., Zimmer Biomet, Smith & Nephew PLC, Ferring Pharmaceuticals B.V., Lifecore Biomedical, LG Life Sciences Ltd., Fidia Farmaceutici S.p.A, F.Hoffmann-La Roche Ltd.
Asia-Pacific is the fastest-growing region for Viscosupplementation Market
| 1. Executive Summary |
| 2. Global Viscosupplementation Market Introduction |
| 2.1. Global Viscosupplementation Market Taxonomy |
| 2.2. Global Viscosupplementation Market Definitions |
| 2.2.1. By Product |
| 2.2.2. By End User |
| 3. Global Viscosupplementation Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Viscosupplementation Market Dynamic Factors - Impact Analysis |
| 3.6. Global Viscosupplementation Market Competition Landscape |
| 4. Global Viscosupplementation Market Analysis,2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Viscosupplementation Market, By Product, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 5.1. Single Injection |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Three Injection |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Five Injection |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Viscosupplementation Market Forecast, By End User, 2018 - 2022 and Forecast, 2020 2026 (Revenue, USD Mn) (Volume, Tons) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Viscosupplementation Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Region, 2023 - 2029 |
| 8. North America ViscosupplementationMarketAnalysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 8.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Single Injection |
| 8.1.2. Three Injection |
| 8.1.3. Five Injection |
| 8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.2.1. Hospitals |
| 8.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 8.2.3. Others |
| 8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. USA |
| 8.3.2. Canada |
| 8.4. North America Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Country, 2023 - 2029 |
| 8.5. North America Viscosupplementation Market Dynamics Trends |
| 9. Europe Viscosupplementation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 9.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Single Injection |
| 9.1.2. Three Injection |
| 9.1.3. Five Injection |
| 9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Hospitals |
| 9.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 9.2.3. Others |
| 9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. France |
| 9.3.4. Spain |
| 9.3.5. Italy |
| 9.3.6. Russia |
| 9.3.7. Poland |
| 9.3.8. Rest of Europe |
| 9.4. Europe Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Country,2023 - 2029 |
| 9.5. Europe Viscosupplementation Market Dynamics Trends |
| 10. Asia-Pacific Viscosupplementation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 10.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Single Injection |
| 10.1.2. Three Injection |
| 10.1.3. Five Injection |
| 10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Hospitals |
| 10.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 10.2.3. Others |
| 10.3. Country Analysis2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Japan |
| 10.3.2. China |
| 10.3.3. India |
| 10.3.4. ASEAN |
| 10.3.5. Australia & New Zealand |
| 10.3.6. Rest of Asia-Pacific |
| 10.4. Asia-Pacific Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Country,2023 - 2029 |
| 10.5. Asia-Pacific Viscosupplementation Market Dynamics Trends |
| 11. Latin America Viscosupplementation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 11.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Single Injection |
| 11.1.2. Three Injection |
| 11.1.3. Five Injection |
| 11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Hospitals |
| 11.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 11.2.3. Others |
| 11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Brazil |
| 11.3.2. Mexico |
| 11.3.3. Argentina |
| 11.3.4. Rest of Latin America |
| 11.4. Latin America Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Country,2023 - 2029 |
| 11.5. Latin America Viscosupplementation Market Dynamics Trends |
| 12. Middle East and Africa Viscosupplementation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, Tons) |
| 12.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Single Injection |
| 12.1.2. Three Injection |
| 12.1.3. Five Injection |
| 12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Hospitals |
| 12.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 12.2.3. Others |
| 12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Gulf Cooperation Council (GCC) Countries |
| 12.3.2. Israel |
| 12.3.3. South Africa |
| 12.3.4. Rest of MEA |
| 12.4. MEA Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Country,2023 - 2029 |
| 12.5. MEA Viscosupplementation Market Dynamics Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, End User& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. Allergan |
| 13.2.2. Sanofi |
| 13.2.3. Hoffmann-La Roche |
| 13.2.4. Smith & Nephew Plc |
| 13.2.5. Zimmer Biomet |
| 13.2.6. Anika Therapeutics Inc. |
| 13.2.7. Ferring B.V. |
| 13.2.8. Bioventus |
| 13.2.9. Fidia Farmaceutici S.P.A. |
| 13.2.10. Regen Lab SA |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
- Allergan
- Sanofi
- Hoffmann-La Roche
- Smith & Nephew Plc
- Zimmer Biomet
- Anika Therapeutics Inc.
- Ferring B.V.
- Bioventus
- Fidia Farmaceutici S.P.A.
- Regen Lab SA